tiprankstipranks
Inspire Medical reports Q3 adjusted EPS 17c vs. 41c last year
The Fly

Inspire Medical reports Q3 adjusted EPS 17c vs. 41c last year

Reports Q3 revenue $97.5M vs. $74.2M last year. “We have completed the financial restatement process and as of today, all amended filings are complete,” said Lorne Weil, executive chairman of Inspired. “For the first half of 2023, the net impact to Adjusted EBITDA from the restatement was effectively zero, with a $1 million decrease in previously reported results in Q1 offset by a $1 million increase in Q2. The impact to our Adjusted EBITDA for the full year 2022, was a decrease of $0.6 million, from $99.6 million to $99.0 million, or less than 1%. Adjusted EBITDA margin for the third quarter was 27%, but excluding Low Margin Gaming Hardware sales, the margin was 36%, compared to 37% in the prior year quarter.”

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on INSP:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles